check if my insurance covers glp 1 Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss Introducing the GLP-1 Insurance Coverage

Since GLP-1R has been localized by immunocytochemistry in mouse aortic smooth muscle cells, endothelial cells, monocytes, and macrophages, both direct and indirect actions of GLP-1 may contribute to the potential reduction of atherogenesis

About 50% achieved 15% or greater weight loss

In preclinical models, GIP has been shown to decrease food intake and increase energy expenditure therefore resulting in weight reductions, and when combined with GLP-1 receptor agonism, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose and lipids. Incretin hormones are released whenever food is consumed

This direct delivery method ensures nearly 100% bioavailability, whereas sublingual drops achieve only 5-15% of the dose reaching the bloodstream in therapeutically active form

GLP-1 is a hormone that helps regulate appetite, blood sugar, and energy

Mehrtash F, Dushay J, Manson JE